XNAS
QSI
Market cap313mUSD
Jun 10, Last price
1.70USD
1D
-0.58%
1Q
41.67%
IPO
-82.83%
Name
Quantum-Si Inc
Chart & Performance
P/E
—
P/S
102.61
EPS
—
Div Yield, %
—
Shrs. gr., 5y
0.98%
Rev. gr., 5y
%
Revenues
3m
+182.62%
Net income
-101m
L+5.26%
CFO
-88m
L-6.64%
Earnings
Aug 05, 2025
Profile
Quantum-Si incorporated, a life sciences company, develops a single molecule detection platform for sample preparation and sequencing. It offers a proprietary single molecule detection platform for use in semiconductor industry to field proteomics to enable next generation protein sequencing. The company was incorporated in 2013 is based in Guilford, Connecticut.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | |
| Income | ||||||
Revenues | 3,058 182.62% | 1,082 | ||||
Cost of revenue | 61,099 | 110,832 | 116,942 | |||
Unusual Expense (Income) | ||||||
NOPBT | (58,041) | (109,750) | (116,942) | |||
NOPBT Margin | ||||||
Operating Taxes | 56 | 8,601 | ||||
Tax Rate | ||||||
NOPAT | (58,097) | (109,750) | (125,543) | |||
Net income | (101,007) 5.26% | (95,960) -31.96% | (141,043) 58.57% | |||
Dividends | ||||||
Dividend yield | ||||||
Proceeds from repurchase of equity | 34,789 | 149 | 2,757 | |||
BB yield | -9.00% | -0.05% | -1.08% | |||
| Debt | ||||||
Debt current | 3,698 | 3,132 | 1,369 | |||
Long-term debt | 22,198 | 29,040 | 33,523 | |||
Deferred revenue | (4,639) | |||||
Other long-term liabilities | 5,014 | 1,285 | 996 | |||
Net debt | (183,707) | (225,564) | (316,417) | |||
| Cash flow | ||||||
Cash from operating activities | (87,795) | (94,036) | (90,560) | |||
CAPEX | (4,583) | (4,510) | (10,741) | |||
Cash from investing activities | (32,675) | 143,428 | 137,185 | |||
Cash from financing activities | 35,876 | 149 | 1,909 | |||
FCF | (56,294) | (108,001) | (142,268) | |||
| Balance | ||||||
Cash | 209,603 | 257,736 | 351,309 | |||
Long term investments | ||||||
Excess cash | 209,450 | 257,682 | 351,309 | |||
Stockholders' equity | (596,578) | (495,620) | (399,660) | |||
Invested Capital | 829,960 | 785,440 | 772,169 | |||
ROIC | ||||||
ROCE | ||||||
| EV | ||||||
Common stock shares outstanding | 143,196 | 141,300 | 139,255 | |||
Price | 2.70 34.33% | 2.01 9.84% | 1.83 -76.75% | |||
Market cap | 386,629 36.13% | 284,013 11.45% | 254,837 -59.31% | |||
EV | 202,922 | 58,449 | (61,580) | |||
EBITDA | (53,441) | (105,594) | (114,358) | |||
EV/EBITDA | 0.54 | |||||
Interest | 13,246 | |||||
Interest/NOPBT | ||||||